ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)


Volume 23, 46 Issues, 2017


Download PDF Flyer




Current Pharmaceutical Design

This journal supports open access

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
William A. Banks
VAPSHCS/GRECC S-182
Building 1, Room 810A
1600 S. Columbian Way
Seattle, WA 98108
USA


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 2.611
5 - Year: 3

Abstracts Ahead of Print

The overlap between Binge Eating Behaviors and Polycystic Ovarian Syndrome: An etiological integrative model


Chiara Paganini*, Gregory Peterson, Vasilis Stavropoulos and Isabel Krug.


View Abstract


A review on oral liquid as an emerging technology in controlled drug delivery system.


Sangmesh Raosaheb Torne, Angappan Sheela* and N C Sarada.


View Abstract


Ensuring the consistency of biosimilars


Isabel Andujar Perez, Ana Blas-Garcia*, Loreto Carmona and Juan V Esplugues.


View Abstract


Immobilization techniques applied to the development of biocatalysts for the synthesis of nucleoside analogue derivatives


Jorge Abel Trelles* and Maria Jose Lapponiab.


View Abstract


The experience with biosimilars of infliximab in inflammatory bowel disease


Pedro Avila-Ribeiro*, Gionata Fiorino and Silvio Danese.


View Abstract


Peptide Mediated Brain Delivery of Nano- and Submicroparticles: a Synergistic Approach


Mark McCully, Macarena Sanchez-Navarro , Meritxell Teixido* and Ernest Giralt*.


View Abstract


FDG PET/CT Imaging in Diabetic Patients – A Special Emphasis on Imaging of Infection


Zohar Keidar*.


View Abstract


Past and future of Ga-citrate for infection and inflammation imaging


Mariza Vorster, J Buscombe*, Ziauddin Saad and Mike Sathekge.


View Abstract


Nuclear Medicine Imaging in Fever of Unknown Origin: The New Paradigm


Christopher J Palestro* and Charito Love.


View Abstract


Risk Assessment and Monitoring of Antibody Responses to Biosimilars in Chronic Inflammatory Diseases


Iris Detrez and Ann Gils*.


View Abstract


The economic impact of biosimilars on chronic immune-mediated inflammatory diseases


Marta Pentek*, Zsombor Zrubka and Laszlo Gulacsi.


View Abstract


Biosimilars: From extrapolation into off label use


Sizheng Zhao, Jagdish R Nair and Robert J Moots*.


View Abstract


The Experience With Biosimilars Of Infliximab In Rheumatic Diseases


Valderilio Feijó Azevedo, Igor Age Kos and Leonardo Ariello.


View Abstract


The Role of Biosimilars in Patient Access to Therapeutic Antibodies for Immune Mediated Inflammatory Diseases


Mary Ann Chapman*, David Charles and Arturo Loaiza-Bonilla.


View Abstract


Lipid nanoparticles for the delivery of active natural medicines


Huijie Xing, Huan Wang, Baojian Wu and Xingwang Zhang*.


View Abstract


Intranasal lipid nanoparticles for the treatment of neurodegenerative diseases


S. Cunha, H. Almeida, M. H. Amaral*, J. M. Sousa Lobo and A C Silva*.


View Abstract


Platform for Lipid Based Nanocarriers’ Formulation Components and their Potential Effects: A Literature Review


Ragwa Mohamed Farid*, Nancy Abdel Hamid Abou Youssef and Abeer Ahmed Kassem.


View Abstract


Imaging of bacteria: is there any hope for the future based on past experience?


Thomas Ebenhan, Elena Lazzeri and Olivier Gheysens*.


View Abstract


Comparative Selectively Targeted Anti-Neoplastic Cytotoxicity of Three Immunopharmaceuticals with Covalently Bound Fludarabine, Gemcitabine and Dexamethasone Moieties Synthesized Utilizing Organic Chemistry Reactions in a Multi-Phase Regimen


Cody P. Coyne* and Lakshmi Narayanan.


View Abstract


Design and delivery of therapeutic siRNAs: application to MERS-Coronavirus


Sayed Sartaj Sohrab*, Sherif Aly El-Kafrawy, Zeenat Mirza, Mohammad Amjad Kamal and Esam Ibraheem Azhar.


View Abstract


Polyphenols: inflammation


Midori Natsume*.


View Abstract


Polyphenols and Microvascular Function in Humans: A Systematic Review


Kirsty A. Woodward, Richard Draijer, Dick H. J. Thijssen and David A Low*.


View Abstract


Use of E. coli Purine Nucleoside Phosphorylase in the Treatment of Solid Tumors


William B. Parker and Eric J Sorscher*.


View Abstract


Substrate spectra of nucleoside phosphorylases and their potential in the production of pharmaceutically active compounds


Heba Yehia, Sarah Kamel, Katharina Paulick, Peter Neubauer and Anke Wagner*.


View Abstract


Influence of Length and Amino Acid Composition on Dimer Formation of Immunoglobulin based Chimera


Patidar Manoj, Yadav Naveen and Sarat Kumar Dalai*.


View Abstract


Advertisement
RNA Therapeutics

Related Journals




Related eBooks



Webmaster Contact: info@benthamscience.org Copyright © 2017 Bentham Science